Key Events This Week
1 June: Quarterly results reveal sharp decline in sales and profitability
2 June: Valuation metrics shift from very attractive to attractive amid market pressure
5 June: Stock closes at Rs.37.33, down 14.65% for the week
1 June: Quarterly Results Trigger Sharp Decline
Trident Texofab Ltd reported a significant deterioration in its quarterly financial performance for the period ended March 2026. Net sales declined by 12.14% to ₹33.57 crores compared to the previous quarter, signalling weakening demand in the garments and apparels sector. The company swung to a loss after tax (PAT) of ₹0.98 crores, a 275.0% decrease, marking a reversal from profitability to losses.
Operating profitability also worsened, with PBDIT falling to a negative ₹1.09 crores and the operating margin contracting to -3.25%. Profit before tax excluding other income dropped to ₹-1.83 crores, while earnings per share (EPS) declined to ₹-1.34. These figures underscored the company’s operational challenges and inability to generate positive returns from core activities.
Reflecting these results, the company’s Mojo Grade was downgraded to “Strong Sell” on 18 May 2026, with the Mojo Score at a low 23.0, consistent with micro-cap stocks facing significant headwinds. The stock price closed at ₹41.70 on 1 June, down 4.66% on the day, mirroring investor concerns.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
2 June: Valuation Metrics Show Mixed Signals Amid Market Pressure
On 2 June, Trident Texofab’s valuation parameters shifted from very attractive to attractive, reflecting a modest improvement largely driven by price declines rather than fundamental gains. The price-to-earnings (P/E) ratio stood at 34.30, still elevated relative to many peers, while the price-to-book value (P/BV) ratio was 1.09, indicating the stock traded close to its book value.
Other multiples included an enterprise value to EBIT (EV/EBIT) of 26.91 and EV to EBITDA of 18.41, both relatively high compared to industry averages. The EV to capital employed ratio was 1.06, and EV to sales was 0.80, suggesting moderate valuation relative to assets and revenue.
Compared to peers, Trident Texofab’s valuation was more attractive than some very expensive companies like Indiabulls and Aayush Art, but less so than very attractive peers such as India Motor Part and Aeroflex Enterprises. The PEG ratio remained at zero, signalling either no earnings growth or unavailable data, a cautionary note for growth investors.
Despite the valuation upgrade, the company’s return on capital employed (ROCE) was a modest 7.44%, and return on equity (ROE) stood at 3.19%, both below expectations for a stock with a P/E above 30. The stock closed at ₹40.65 on 2 June, down 2.52% on the day, continuing its downward trend.
3–5 June: Continued Price Pressure and Volume Surge
Trident Texofab’s stock price continued to decline over the next three trading sessions. On 3 June, the stock fell 1.43% to ₹40.07 amid a volume increase to 20,359 shares, while the Sensex declined 0.34%. The downward momentum accelerated on 4 June, with the stock dropping 2.80% to ₹38.95 on volume of 17,225 shares, despite a modest Sensex gain of 0.19%.
The week closed on 5 June with a sharp 4.16% fall to ₹37.33, the lowest close of the week, on heavy volume of 27,268 shares. The Sensex also declined marginally by 0.10% that day. This final session’s decline cemented the stock’s weekly loss of 14.65%, a stark underperformance compared to the Sensex’s 0.78% fall.
Trident Texofab Ltd or something better? Our SwitchER feature analyzes this micro-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-01 | Rs.41.70 | -4.66% | 35,077.62 | -0.96% |
| 2026-06-02 | Rs.40.65 | -2.52% | 35,227.64 | +0.43% |
| 2026-06-03 | Rs.40.07 | -1.43% | 35,107.33 | -0.34% |
| 2026-06-04 | Rs.38.95 | -2.80% | 35,175.61 | +0.19% |
| 2026-06-05 | Rs.37.33 | -4.16% | 35,141.95 | -0.10% |
Key Takeaways
Significant Financial Deterioration: The quarter ended March 2026 revealed a sharp decline in sales and a swing to losses, with operating margins turning negative. This deterioration has been a primary driver of the stock’s steep weekly fall.
Valuation Shift Amid Weak Fundamentals: Although valuation metrics improved from very attractive to attractive, this was largely due to price declines rather than operational improvement. Elevated P/E and modest returns on capital highlight ongoing profitability challenges.
Strong Sell Rating and Market Sentiment: The downgrade to a strong sell rating and a low Mojo Score of 20.0 reflect heightened caution among analysts and investors. The stock’s micro-cap status adds to liquidity and volatility risks.
Underperformance Relative to Sensex: The stock’s 14.65% weekly decline far outpaced the Sensex’s 0.78% fall, underscoring the company’s struggles amid broader market stability.
Conclusion
Trident Texofab Ltd’s week was marked by a pronounced decline in share price driven by disappointing quarterly results and a downgrade to a strong sell rating. Despite a modest improvement in valuation metrics, the company’s weak profitability, negative operating margins, and poor returns on capital continue to weigh on investor confidence. The stock’s significant underperformance relative to the Sensex highlights the challenges facing this micro-cap garment sector player. Until there is clear evidence of operational turnaround or earnings growth, the stock remains a high-risk proposition with limited near-term upside.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
